Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs
Ned Latham(Burnet Institute), Rachel Sacks‐Davis(Burnet Institute), Oluwaseun Falade‐Nwulia, Esther Aspinall(Glasgow Caledonian University), Margaret Hellard(The Alfred Hospital), Alyona Mazhnaya(Johns Hopkins University), Marina B. Klein(Royal Victoria Regional Health Centre), Julie Bouscaillou(Institut des Mondes Africains), Sharon Hutchinson(Glasgow Caledonian University), Stelliana Goutzamanis(Burnet Institute), Joseph Doyle(The Alfred Hospital), Zinia Li(Burnet Institute), Frederick L. Altice(Heidelberg University), Niklas Luhmann(World Health Organization - Pakistan), Paul A. Agius(Burnet Institute), Alisa Pedrana(Burnet Institute), Anna Palmer(Burnet Institute), Sahar Saeed(McGill University), Magnús Gottfreðsson(Reykjavík University), Joost W. Vanhommerig(Burnet Institute)
Cited by 54
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|726
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
|Annals of Internal Medicine|2012|595
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539